Analyst Ratings for [ELV] Elevance Health Inc.

7/21/25	Downgrades	Buy Hold	X
ELV Elevance Health Argus
7/18/25	Downgrades	Outperform Mkt Perform	X
ELV Elevance Health Leerink Partners
$310
4/15/25	Downgrades	Outperform Neutral	X
ELV Elevance Health Robert W. Baird
$529
3/17/25	Upgrades	Hold Buy	X
ELV Elevance Health Argus
$450
1/22/25	Downgrades	Overweight Eq-Weight	X
ELV Elevance Health Stephens
$520 $440
10/18/24	Downgrades	Buy Hold	X
ELV Elevance Health Argus
7/18/24	Downgrades	Buy Neutral	X
ELV Elevance Health BofA Securities
$646 $530
6/24/24	Initiated	Overweight	X
ELV Elevance Health Morgan Stanley
$643
5/30/24	Initiated	Outperform	X
ELV Elevance Health Robert W. Baird
$649
3/6/24	Initiated	Overweight	X
ELV Elevance Health Barclays
$584
7/12/23	Downgrades	Outperform Peer Perform	X
ELV Elevance Health Wolfe Research
4/27/23	Upgrades	Eq-Weight Overweight	X
ELV Elevance Health Morgan Stanley
$500 $571
4/21/23	Initiated	Overweight	X
ELV Elevance Health Cantor Fitzgerald
$547
3/28/23	Upgrades	Sec Perform Outperform	X
ELV Elevance Health RBC Capital Mkts
$523 $572
9/9/22	Upgrades	Neutral Buy	X
ELV Elevance Health BofA Securities
$535 $575

ELV Elevance Health Inc.

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.